365 related articles for article (PubMed ID: 33423903)
1. Factors associated with the intensity of government remunerated and unremunerated service provision in community pharmacies.
Czarniak P; Krass I; Sunderland B; Sim TF; Carter S
Res Social Adm Pharm; 2021 Sep; 17(9):1614-1622. PubMed ID: 33423903
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional survey of enhanced and extended professional services in community pharmacies: A pharmacy perspective.
Sim TF; Wright B; Hattingh L; Parsons R; Sunderland B; Czarniak P
Res Social Adm Pharm; 2020 Apr; 16(4):511-521. PubMed ID: 31300355
[TBL] [Abstract][Full Text] [Related]
3. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
Hattingh HL; Kelly F; Fowler J; Wheeler AJ
Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
[TBL] [Abstract][Full Text] [Related]
4. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
[TBL] [Abstract][Full Text] [Related]
5. Exploring pharmacists' views on an in-pharmacy medication review program in Australia using a mixed-methods design.
Buss VH; Shield A; Kosari S; Peterson GM; Naunton M
Int J Clin Pharm; 2020 Dec; 42(6):1385-1395. PubMed ID: 32803556
[TBL] [Abstract][Full Text] [Related]
6. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
8. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia.
Wibowo Y; Berbatis C; Joyce A; Sunderland VB
Rural Remote Health; 2010; 10(3):1400. PubMed ID: 20684656
[TBL] [Abstract][Full Text] [Related]
9. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
[TBL] [Abstract][Full Text] [Related]
10. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
Gargya D; Mirkazemi C; Curtain C
J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
[TBL] [Abstract][Full Text] [Related]
11. A national survey exploring oral healthcare service provision across Australian community pharmacies.
Freeman CR; Abdullah N; Ford PJ; Taing MW
BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
[TBL] [Abstract][Full Text] [Related]
12. A national survey of pharmacists and interns in Aotearoa New Zealand: provision and views of extended services in community pharmacies.
McDonald J; Morris C; Pledger M; Dunn P; Fa'asalele Tanuvasa A; Smiler K; Cumming J
BMC Health Serv Res; 2021 Oct; 21(1):1147. PubMed ID: 34688303
[TBL] [Abstract][Full Text] [Related]
13. The Inverse Care Law might not apply to preventative health services in community pharmacy.
Zonneveld S; Versace VL; Krass I; Clark RA; Shih S; Detert Oude Weme S; Mc Namara KP
Res Social Adm Pharm; 2021 May; 17(5):875-884. PubMed ID: 33092979
[TBL] [Abstract][Full Text] [Related]
14. Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs.
Giannetti V; Caley CF; Kamal KM; Covvey JR; McKee J; Wells BG; Najarian DM; Dunn TJ; Vadagam P
Int J Clin Pharm; 2018 Oct; 40(5):1096-1105. PubMed ID: 29862460
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the first pharmacist-administered vaccinations in Western Australia: a mixed-methods study.
Hattingh HL; Sim TF; Parsons R; Czarniak P; Vickery A; Ayadurai S
BMJ Open; 2016 Sep; 6(9):e011948. PubMed ID: 27650763
[TBL] [Abstract][Full Text] [Related]
16. A qualitative case study exploring the implementation of pharmacist care planning services in community pharmacies.
Hughes CA; Breault RR; Schindel TJ
J Am Pharm Assoc (2003); 2020; 60(4):580-588.e2. PubMed ID: 31953119
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care C-reactive protein testing service for respiratory tract infections in community pharmacy: a qualitative study of service uptake and experience of pharmacists.
Czarniak P; Chalmers L; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B; Sim TF
Int J Clin Pharm; 2022 Apr; 44(2):466-479. PubMed ID: 35088232
[TBL] [Abstract][Full Text] [Related]
18. Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.
Taylor S; Cairns A; Glass BD
BMJ Open; 2022 Apr; 12(4):e057011. PubMed ID: 35365533
[TBL] [Abstract][Full Text] [Related]
19. Implementation of technician-driven medication therapy management program in community pharmacies.
Burnside TPT; Scott NJ; Smith MG
J Am Pharm Assoc (2003); 2019; 59(4S):S156-S160.e2. PubMed ID: 31326039
[TBL] [Abstract][Full Text] [Related]
20. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
Wibowo Y; Sunderland B; Hughes J
Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
